NO955071L - abeo-Ergolin-derivater som 5HT1A-ligander - Google Patents

abeo-Ergolin-derivater som 5HT1A-ligander

Info

Publication number
NO955071L
NO955071L NO955071A NO955071A NO955071L NO 955071 L NO955071 L NO 955071L NO 955071 A NO955071 A NO 955071A NO 955071 A NO955071 A NO 955071A NO 955071 L NO955071 L NO 955071L
Authority
NO
Norway
Prior art keywords
group
alkyl
phenyl
formula
hydrogen atom
Prior art date
Application number
NO955071A
Other languages
English (en)
Other versions
NO955071D0 (no
Inventor
Sergio Mantegani
Tiziano Bandiera
Enzo Brambilla
Carla Caccia
Nicola Carfagna
Original Assignee
Pharmacia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Spa filed Critical Pharmacia Spa
Publication of NO955071L publication Critical patent/NO955071L/no
Publication of NO955071D0 publication Critical patent/NO955071D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Det tilveiebringes forbindelser med formel (I), hvor. Rer et hydrogen-, klor- eller bromatom eller en metyl-, metyltio-, hydroksy-, cyano-, karboksamido-eller nitrogruppe; Rer en C-C-alkyl eller allyl-gruppe; Rog Rer uavhengig et hydrogenatom, en lineær eller forgrenet C-C-alkylgruppe, en lineær eller forgrenet-C-alkenylgruppe, en C-Cg-sykloalkyl-C-C-alkylgruppe, en fenyl-C-Calkyl, en fenyl-C-C-alkenyl eller fenylgruppe: hvilke grupper eventu-. elt er substituert med en C^- C^ alkyl-, C-C-al-koksy-, trifluoremetyl-, hydroksy- eller amino-. I. gruppe: eller en gruppe av formelen (a) hvor Rer et hydrogenatom eller en C-C-alkylgruppe, og Rer en fenylgruppe, en substituert fenylgruppe som beskrevet ovenfor eller en hetrosyklisk ring med 5-6 ringatomer inklusive ett eller to hetroatomer uavhengig valgt fra oksygen, svovel og nitrogen; de stiplede linjer ved stillingene 2-3 og 9-10 repre-senterer uavhengig en enkelt- eller dobbeltbinding;. Rer et hydrogen-, brom-, fluor- eller jodatom. eller en metoksy-, cyano-, karboksamido-, nitro-, metyltio- eller trifluormetylgruppe eller en gruppe med formel NRRg, hvor Rog Rg uavhengig er et hydrogenatom eller en alkyl-, acetyl-, trifluor-acetyl- eller metansulfonulgruppe. R er et hydrogenatom, en lineær eller forgrenet C-alkylgruppe, en metansulfonulgruppe, en acetylgruppe eller en gruppe med formel -C(0)-NRRhvor Rog Rg er som definert ovenfor; eller et farmasøytisk akseptabel salt der-. av. En fremgangsmåte ved deres fremstilling og de farmasøytiske sammensetninger omfattende dem er også beskrevet.
NO955071A 1994-04-18 1995-12-14 abeo-Ergolin-derivater som 5HT1A-ligander NO955071D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9407637A GB9407637D0 (en) 1994-04-18 1994-04-18 Serotoninergic abeo-ergoline derivatives
PCT/EP1995/001398 WO1995028403A1 (en) 1994-04-18 1995-04-13 Abeo-ergoline derivatives as 5ht1a ligands

Publications (2)

Publication Number Publication Date
NO955071L true NO955071L (no) 1995-12-14
NO955071D0 NO955071D0 (no) 1995-12-14

Family

ID=10753700

Family Applications (1)

Application Number Title Priority Date Filing Date
NO955071A NO955071D0 (no) 1994-04-18 1995-12-14 abeo-Ergolin-derivater som 5HT1A-ligander

Country Status (16)

Country Link
US (1) US6284896B1 (no)
EP (1) EP0708777B1 (no)
JP (1) JPH08512059A (no)
KR (1) KR960703126A (no)
CN (1) CN1126996A (no)
AT (1) ATE255111T1 (no)
CA (1) CA2163773A1 (no)
DE (1) DE69532187T2 (no)
ES (1) ES2211903T3 (no)
FI (1) FI955933A7 (no)
GB (1) GB9407637D0 (no)
HU (1) HUT73430A (no)
NO (1) NO955071D0 (no)
NZ (1) NZ284472A (no)
PL (1) PL312229A1 (no)
WO (1) WO1995028403A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000059909A1 (en) * 1999-03-30 2000-10-12 Shionogi & Co., Ltd. Heterocyclic compounds having affinities for serotonin receptors
AU2001283393B2 (en) * 2000-08-16 2005-09-22 Pharmacia & Upjohn Company Compounds for the treatment of addictive disorders
AU2001286259A1 (en) * 2000-09-22 2002-04-02 Shionogi And Co., Ltd. Tricyclic indole compounds having affinity for serotonin receptor
JP2026525309A (ja) * 2023-07-14 2026-07-29 2エイ バイオサイエンシズ、インコーポレイテッド 置換されたエルゴリン

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1482871A (en) * 1975-03-18 1977-08-17 Farmaceutici Italia Tetracyclic indole derivatives
IL59507A (en) 1979-03-16 1984-01-31 Erba Farmitalia 5-(10-9)abeo-6-methylergoline derivatives,their preparation and pharmaceutical compositions containing them
GB8714767D0 (en) 1987-06-24 1987-07-29 Erba Farmitalia Egoline derivatives
GB8612366D0 (en) 1986-05-21 1986-06-25 Erba Farmitalia Ergoline esters
GB8702364D0 (en) 1987-02-03 1987-03-11 Erba Farmitalia Ergolinyl heterocycles
ES2032570T3 (es) 1987-11-20 1993-02-16 Farmitalia Carlo Erba S.R.L. Derivados antiparkinson de ergolina. (reserva del art. 167.2 cpe).
JPH04504582A (ja) 1990-01-25 1992-08-13 フアルミタリア・カルロ・エルバ・エツセ・エルレ・エルレ エルゴリン誘導体を製造する方法
US5244911A (en) * 1991-03-28 1993-09-14 Eli Lilly And Company 6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz(cd)indoles and pharmaceutical use thereof
PT628042E (pt) 1992-12-24 2002-01-30 Pharmacia & Upjohn Spa Derivados de ergolina serotoninergicos

Also Published As

Publication number Publication date
AU2307395A (en) 1995-11-10
US6284896B1 (en) 2001-09-04
EP0708777A1 (en) 1996-05-01
DE69532187T2 (de) 2004-09-02
NZ284472A (en) 1998-01-26
KR960703126A (ko) 1996-06-19
PL312229A1 (en) 1996-04-01
DE69532187D1 (de) 2004-01-08
FI955933A0 (fi) 1995-12-11
FI955933L (fi) 1995-12-11
AU685268B2 (en) 1998-01-15
CN1126996A (zh) 1996-07-17
FI955933A7 (fi) 1995-12-11
WO1995028403A1 (en) 1995-10-26
ES2211903T3 (es) 2004-07-16
GB9407637D0 (en) 1994-06-08
HU9503718D0 (en) 1996-03-28
HUT73430A (en) 1996-07-29
EP0708777B1 (en) 2003-11-26
JPH08512059A (ja) 1996-12-17
ATE255111T1 (de) 2003-12-15
NO955071D0 (no) 1995-12-14
CA2163773A1 (en) 1995-10-26

Similar Documents

Publication Publication Date Title
MX154758A (es) Procedimiento para preparacion de derivados de succinimida
IL161559A0 (en) Dibenzylamine derivatives and pharmaceutical compositions containing the same
DK0870765T3 (da) Aminothiazolderivat, lægemiddel indeholdende samme og mellemprodukt til fremstilling af forbindelsen
DE69418704D1 (de) Anthranilsäure derivate
DK0928788T3 (da) Imidazolidin-4-on-derivater, der er nyttige som anticancer-midler
IE42410L (en) Olefinic derivatives of aminoacids.
YU16899A (sh) Aralkil i aralkiliden heterociklicni laktami i imidi
MY149463A (en) Novel compounds
NO20080738L (no) Fremgangsmater for neurobeskyttelse
DK0594263T3 (da) Mellemprodukter til fremstilling af thioalkylthio-cephalosporinderivater
DK0437030T3 (da) Anvendelse af 4-substituerede imidazoler til nedsættelse af det intraoculære tryk
CS34491A3 (en) Substituted benzimidazole and idazole derivatives, process of their preparation and the use of these derivatives
DK0458551T3 (da) Spiro-isoquinolin-pyrrolidiner og analoge deraf, som er anvendelige som aldosereduktase-inhibitorer.
NZ221699A (en) Pyridazinone derivatives; pharmaceutical compositions and intermediates
FI844333A0 (fi) 11-substituerade 5h,11h-pyrrolo/2,1-c/ /1,4/benzoxazepiner, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
NZ241157A (en) Heterocyclically-substituted benzofuran derivatives, preparation and pharmaceutical compositions thereof
NO960441L (no) Benzopyraner og farmasöytiske forbindelser inneholdende dem
AU6731100A (en) Integrase inhibitors containing aromatic heterocycle derivatives
DK508484A (da) N-substituerede isoquinolinderivater og farmaceutisk praeparat indeholdende dem
GR3001765T3 (en) Imidazolidinedione derivatives
NO885224L (no) Fremgangsmaate for fremstilling av 1,4-disubstituerte-piperidinylderivater.
DE69005318D1 (de) 1,8-Benzonaphthyridinderivate, ihre Herstellung und diese enthaltende Zusammensetzungen.
IT1150955B (it) Derivati 3h-naft(1.2-d)-imidazolici il procedimento per la loro preparazione, il loro uso come agenti antiinfiammatori e le composizioni farmaceutiche che li contengono
ATE147376T1 (de) Heterocyclische derivate
ES8604599A1 (es) Un procedimiento para preparar derivados de isoxazolquino- leina